Overview
Fusarium infections encompass a range of mycoses caused by fungi of the Fusarium genus, often affecting immunocompromised individuals, particularly post-transplant patients. These infections can manifest as cutaneous lesions, disseminated disease, and rarely involve systemic complications leading to multiorgan failure 2.Diagnosis
Clinical Presentation: Vesicular skin lesions may initially mimic viral infections, necessitating histopathological examination for definitive diagnosis 2.
Laboratory Tests: Culture of clinical samples (e.g., stool, sputum) is crucial for identifying Fusarium species 2.
Histopathology: Recommended for differentiating between viral and fungal blistering conditions in transplant recipients 2.Management
Antifungal Therapy: Specific antifungal agents such as voriconazole or echinocandins are typically used, though dosing specifics are not detailed in the provided abstracts 2.
Supportive Care: Management includes addressing multiorgan dysfunction with supportive measures tailored to affected organs 2.Special Populations
Immunocompromised Patients: Particularly vulnerable, especially post-stem cell transplantation, where early recognition and intervention are critical 2.
Pregnancy: No specific data provided in the abstracts regarding Fusarium infections in pregnant women or fetal implications 1.Key Recommendations
Early Histopathological Examination: When transplant recipients present with vesicular skin lesions, perform histopathological examination to differentiate between viral and fungal etiologies (Evidence: Moderate 2).
Culture Confirmation: Confirm Fusarium infection through culture of relevant clinical samples (e.g., stool, sputum) (Evidence: Moderate 2).
Initiate Antifungal Therapy: Early initiation of appropriate antifungal therapy, such as voriconazole or echinocandins, for suspected disseminated fusariosis (Evidence: Expert opinion 2).References
1 Yuan TM, Yu HM, Gu WZ, Li JP. White matter damage and chemokine induction in developing rat brain after intrauterine infection. Journal of perinatal medicine 2005. link
2 Hamaki T, Kami M, Kishi A, Kusumi E, Kishi Y, Iwata H et al.. Vesicles as initial skin manifestation of disseminated fusariosis after non-myeloablative stem cell transplantation. Leukemia & lymphoma 2004. link
3 Krska R. Performance of modern sample preparation techniques in the analysis of Fusarium mycotoxins in cereals. Journal of chromatography. A 1998. link00003-x)